Beranda › Dermatitis Atopik (Eksim) › Maryland
Uji klinis Dermatitis Atopik (Eksim) di Maryland
16 studi untuk Dermatitis Atopik (Eksim) mencari peserta di lokasi di Maryland.
Kota di Maryland
Teks studi resmi (Bahasa Inggris)
Natural History and Genetics of Food Allergy and Related Conditions
- National Institutes of Health Clinical Center, Bethesda
Menerima pesertaStudi observasionalSukarelawan sehat diterima
1 Day – 99 Years · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT02504853Evaluating the Safety and Tolerability of Baricitinib in Patients With Job Syndrome With Lupus-Like Disease and/or Atopic Dermatitis
- National Institutes of Health Clinical Center, Bethesda
Menerima pesertaFase 1
Usia 12 hingga 120 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT07262983Effects of Treatments on Atopic Dermatitis
- National Institutes of Health Clinical Center, Bethesda
Menerima pesertaFase 2Sukarelawan sehat diterima
Usia 2 hingga 50 · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT01631617A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
- Investigational Site, Rockville
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT07003425Metabolic Profiling of Immune Responses in Immune-mediated Diseases
- National Institutes of Health Clinical Center, Bethesda
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT04864886Studies of Skin Microbes in Healthy People and in People With Skin Conditions
- National Institutes of Health Clinical Center, Bethesda
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 2 hingga 100 · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT00605878Evaluation of a Non-Invasive Device for Early Detection of Atopic Dermatitis Flares
- U.S. Dermatology Partners Rockville, Rockville
Menerima pesertaStudi observasional
Usia 12 hingga 89 · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT07645820A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
- Chesapeake Clinical Research, Inc, Pasadena
Menerima pesertaFase 2
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 28 Agu 2026 · NCT07599813Food-Specific and Component IgE Threshold Levels That Predict Food Allergy in People With Elevated Total Serum IgE Levels and Atopic Dermatitis
- National Institutes of Health Clinical Center, Bethesda
Menerima pesertaFase 2
Usia 3 hingga 21 · Semua jenis kelamin · Diperbarui 26 Agu 2026 · NCT03835767Cardamom and Topical Roseomonas in Atopic Dermatitis
- National Institutes of Health Clinical Center, Bethesda
Menerima pesertaFase 2
Usia 2 hingga 100 · Semua jenis kelamin · Diperbarui 13 Agu 2026 · NCT06096857A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis
- Maryland Allergy & Asthma Center /ID# 268032, Lanham
Menerima pesertaFase 3
Usia 2 hingga 11 · Semua jenis kelamin · Diperbarui 6 Agu 2026 · NCT06461897A Biorepository of Multiple Allergic Diseases (MADREP) With Longitudinal Follow-Up
- National Institutes of Health Clinical Center, Bethesda
Menerima pesertaStudi observasional
Usia 3 hingga 100 · Semua jenis kelamin · Diperbarui 17 Jul 2026 · NCT06732414A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
- Maryland Laser Skin and Vein, Hunt Valley
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 4 Mei 2026 · NCT05995964Dupilumab De-escalation in Pediatric Atopic Dermatitis
- Johns Hopkins Univerisity, Baltimore
Menerima pesertaFase 4
Usia 1 hingga 17 · Semua jenis kelamin · Diperbarui 20 Apr 2026 · NCT06116526Registry for Systemic Eczema Treatments
- Johns Hopkins University, Baltimore
Menerima pesertaStudi observasional
Usia 1 hingga 26 · Semua jenis kelamin · Diperbarui 7 Apr 2026 · NCT06136767Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
- Galderma Investigational Site 7098, Columbia
- Galderma Investigational Site 8012, Glenn Dale
- Galderma Investigational Site 7068, Rockville
Menerima pesertaStudi observasional
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 13 Mar 2026 · NCT06988605Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.